Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Arformoterol tartrate
Drug ID BADD_D00160
Description Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma.
Indications and Usage A bronchodilator used for the long term, symptomatic treatment of reversible bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Marketing Status approved; investigational
ATC Code R03CC15; R03AC13
DrugBank ID DB01274
KEGG ID D02981
MeSH ID D000068759
PubChem ID 9827062
TTD Drug ID D0D1DI
NDC Product Code 64567-0022; 62332-633; 62756-277; 66039-909; 70748-175; 63402-911; 14501-0077; 0093-5955; 50384-4279; 70756-612; 69097-168; 53104-7731
UNII 5P8VJ2I235
Synonyms Formoterol Fumarate | Formoterol Fumarate, ((R*,R*)-(+-))-isomer | 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate | BD 40A | Formoterol | Eformoterol | Oxis | Arformoterol | Formoterol, ((R*,R*)-(+-))-isomer | Foradil
Chemical Information
Molecular Formula C23H30N2O10
CAS Registry Number 200815-49-2
SMILES CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abscess11.01.08.001---
Agitation17.02.05.012; 19.06.02.001--
Angina pectoris02.02.02.002; 24.04.04.002--
Arrhythmia02.03.02.001---
Arteriosclerosis24.04.02.001---
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Asthenia08.01.01.001---
Atrial flutter02.03.03.003--
Atrioventricular block02.03.01.002---
Back pain15.03.04.005--
Bone disorder15.02.04.004---
Breast neoplasm16.10.02.001; 21.05.01.004---
Bronchitis11.01.09.001; 22.07.01.001--
Cardiac failure congestive02.05.01.002---
Cerebral infarction17.08.01.004; 24.04.06.002---
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Chronic obstructive pulmonary disease22.03.01.007---
Constipation07.02.02.001--
Cystitis11.01.14.001; 20.03.02.002--
Dehydration14.05.05.001--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysphonia17.02.08.004; 19.19.03.002; 22.12.03.006--
Dyspnoea02.11.05.003; 22.02.01.004--
Electrocardiogram QT prolonged13.14.05.004--
Electrocardiogram T wave inversion13.14.05.007---
Fatigue08.01.01.002--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages